最新 Form 144 申報
公司的高階主管、董事與其他關係人要賣出受限制股票或控制股份，而且三個月內預計賣出超過 5,000 股或 5 萬美元時，下單時要交 Form 144。它是預計賣出的通知；高階主管、董事實際賣出之後，會再申報 Form 4。13D、13G 與 Form 144 是什麼
Form 144 申報
由新到舊。有 Form 144/A 修正的申報只列修正後的那一份。
近 365 天的申報（依美東日期）。
本站的 Form 144 申報：2023/1/4 到 2026/10/5。
市值明顯填錯的申報不列在這裡，也不算進合計；公司的頁面照樣列出並加註。判斷方式是把市值除以股數，得到的每股價格遠高於這家公司在預計賣出日前後的 Form 4 成交價與 13F 持股的價格，就當成填錯。
- 申報份數
- 413
- 預計賣出市值
- $14.1 億
- 賣方
- 117
- 公司
- 37
- 依 10b5-1 計畫
- 220
| 公司 | 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|---|
| KRYSKrystal Biotech, Inc. | 2026/5/2610:30 ET | Thomas John Charles高階主管 | 642 | $19.4 萬 | 2026/5/2610b5-1 | Fidelity Brokerage Services LLC | SEC |
| AMPGAmpliTech Group, Inc. | 2026/5/2216:01 ET | Mazziota Daniel Richard董事 | 1.00 萬 | $4.95 萬 | 2026/5/22 | Charles Schwab Corp. | SEC |
| ARTVArtiva Biotherapeutics, Inc. | 2026/5/1819:54 ET | Heather Raymon高階主管 · 董事 | 3,500 | $3.23 萬 | 2026/5/18 | Morgan Stanley Smith Barney LLC | SEC |
| ARTVArtiva Biotherapeutics, Inc. | 2026/5/1819:53 ET | Christopher P. Horan高階主管 · 董事 | 7,500 | $6.92 萬 | 2026/5/18 | Morgan Stanley Smith Barney LLC | SEC |
| ARTVArtiva Biotherapeutics, Inc. | 2026/5/1819:51 ET | Jennifer Bush高階主管 · 董事 | 9,000 | $8.30 萬 | 2026/5/18 | Morgan Stanley Smith Barney LLC | SEC |
| ARTVArtiva Biotherapeutics, Inc. | 2026/5/1819:49 ET | Subhashis Banerjee高階主管 · 董事 | 7,000 | $6.45 萬 | 2026/5/18 | Morgan Stanley Smith Barney LLC | SEC |
| ARTVArtiva Biotherapeutics, Inc. | 2026/5/1819:48 ET | Fred Aslan, M.D.高階主管 · 董事 | 2.80 萬 | $25.8 萬 | 2026/5/18 | Morgan Stanley Smith Barney LLC | SEC |
| ATRAAtara Biotherapeutics, Inc. | 2026/5/1816:45 ET | Nguyen AnhCo董事 · 高階主管 | 5,981 | $6.27 萬 | 2026/5/18 | Morgan Stanley Smith Barney LLC | SEC |
| ATRAAtara Biotherapeutics, Inc. | 2026/5/1816:44 ET | Grant-Huerta Yanina高階主管 | 2,754 | $2.89 萬 | 2026/5/18 | Morgan Stanley Smith Barney LLC | SEC |
| CACCCredit Acceptance Corp | 2026/5/1816:14 ET | Elliott Nicholas J高階主管 | 1,815 | $100.3 萬 | 2026/5/1810b5-1 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2026/5/1814:13 ET | Roe Peggy高階主管 | 3,000 | $108.5 萬 | 2026/5/18 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/5/1520:03 ET | Piskel Kyle高階主管 | 3,160 | $4.05 萬 | 2026/5/18 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/5/1510:06 ET | Boulding Mark Elliott高階主管 | 2,812 | $20.4 萬 | 2026/5/1510b5-1 | Fidelity Brokerage Services LLC | SEC |
| IOTSamsara Inc. | 2026/5/1316:42 ET | Kirchhoff Benjamin Louis高階主管 | 2,554 | $7.02 萬 | 2026/5/1310b5-1 | Charles Schwab & Co., Inc. | SEC |
| MARMarriott International Inc | 2026/5/1309:48 ET | Mao Yibing高階主管 | 4,816 | $167.5 萬 | 2026/5/13 | Fidelity Brokerage Services LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/5/1116:44 ET | Patrick Burnett高階主管 | 222 | $4,673.1 | 2026/5/11 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/5/1116:35 ET | Latha Vairavan高階主管 | 435 | $9,156.75 | 2026/5/11 | Merrill Lynch | SEC |
| RIOTRiot Platforms, Inc. | 2026/5/1116:11 ET | Jason LesCEO · 董事 | 17.5 萬 | $421.4 萬 | 2026/5/1110b5-1 | J.P. Morgan Securities LLC | SEC |
| MPMP Materials Corp. | 2026/5/816:18 ET | Elliot Hoops高階主管 | 6,958 | $52.2 萬 | 2026/5/810b5-1 | Merrill | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/5/816:15 ET | Boulding Mark Elliott高階主管 | 3,540 | $28.0 萬 | 2026/5/810b5-1 | Fidelity Brokerage Services LLC | SEC |
| ATRAAtara Biotherapeutics, Inc. | 2026/5/720:30 ET | Panacea Innovation Ltd持股 10% 以上股東 | 31.3 萬 | $316.5 萬 | 2026/5/7 | Cantor Fitzgerald | SEC |
| CACCCredit Acceptance Corp | 2026/5/616:33 ET | Elliott Nicholas J高階主管 | 1,672 | $92.2 萬 | 2026/5/610b5-1 | Fidelity Brokerage Services LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/5/417:19 ET | Patrick Burnett高階主管 | 684 | $1.61 萬 | 2026/5/4 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/5/417:18 ET | Latha Vairavan高階主管 | 1,341 | $3.17 萬 | 2026/5/4 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/5/417:18 ET | Todd Watanabe高階主管 | 3,172 | $7.49 萬 | 2026/5/4 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/5/417:05 ET | Masaru Matsuda高階主管 | 8,256 | $19.2 萬 | 2026/5/410b5-1 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/5/116:04 ET | Howard Welgus董事 | 7,144 | $16.4 萬 | 2026/5/110b5-1 | Merrill | SEC |
| USCBUscb Financial Holdings, Inc. | 2026/4/3012:40 ET | Patriot Financial Partners GP II, LLC持股 10% 以上股東 | 5.00 萬 | $92.5 萬 | 2026/4/30 | Keefe, Bruyette & Woods, Inc. | SEC |
| VIRVir Biotechnology, Inc. | 2026/4/3009:55 ET | Eisner Mark前高階主管 | 8.90 萬 | $91.6 萬 | 2026/4/30 | Fidelity Brokerage Services LLC | SEC |
| FTHFaeth Therapeutics, Inc. | 2026/4/2915:26 ET | Cambrian BioPharma Inc持股 10% 以上股東 | 15.5 萬 | $495.7 萬 | 2026/4/29 | Fidelity Brokerage Services LLC | SEC |
| IOTSamsara Inc. | 2026/4/1316:00 ET | Kirchhoff Benjamin Louis高階主管 | 2,480 | $6.45 萬 | 2026/4/1310b5-1 | Charles Schwab & Co., Inc. | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/4/816:58 ET | Harlan Robins高階主管 | 1.00 萬 | $14.8 萬 | 2026/4/810b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/4/816:58 ET | Chad Robins高階主管 | 3.73 萬 | $55.3 萬 | 2026/4/810b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/4/816:33 ET | Francis Lo高階主管 | 2.26 萬 | $30.9 萬 | 2026/4/810b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/4/617:22 ET | Chad Robins高階主管 | 8.33 萬 | $117.3 萬 | 2026/4/610b5-1 | Goldman Sachs & Co. LLC | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/4/616:13 ET | Boulding Mark Elliott高階主管 | 2,265 | $15.7 萬 | 2026/4/610b5-1 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2026/4/615:23 ET | De Backer Marianne高階主管 · 董事 | 7.26 萬 | $66.4 萬 | 2026/4/6 | Fidelity Brokerage Services LLC | SEC |
| IOTSamsara Inc. | 2026/4/116:41 ET | Dominic Phillips高階主管 | 5.92 萬 | $187.7 萬 | 2026/4/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/4/116:02 ET | Howard Welgus董事 | 1.00 萬 | $23.9 萬 | 2026/4/110b5-1 | Merrill | SEC |
| SMTCSemtech Corp | 2026/4/114:39 ET | Green Jason Elliot高階主管 | 7,500 | $61.3 萬 | 2026/4/1 | Fidelity Brokerage Services LLC | SEC |
| TFPMTriple Flag Precious Metals Corp. | 2026/3/3120:06 ET | Elliott Investment Management, L.P. (1)股東 | 388.0 萬 | $1.28 億 | 2026/3/31 | Goldman Sachs & Co. LLC | SEC |
| IOTSamsara Inc. | 2026/3/3116:45 ET | Bicket John高階主管 · 董事 · 持股 10% 以上股東 | 131.9 萬 | $4,147 萬 | 2026/3/3110b5-1 | Charles Schwab & Co., Inc. | SEC |
| IOTSamsara Inc. | 2026/3/3116:44 ET | Biswas Sanjit高階主管 · 董事 · 持股 10% 以上股東 | 131.9 萬 | $4,148 萬 | 2026/3/3110b5-1 | Charles Schwab & Co., Inc. | SEC |
| LEGNLegend Biotech Corp | 2026/3/2616:27 ET | Huang Ying高階主管 · 董事 | 4,968 | $8.71 萬 | 2026/3/26 | Fidelity Brokerage Services LLC | SEC |
| LEGNLegend Biotech Corp | 2026/3/2616:20 ET | Yeung Jessie高階主管 | 1,862 | $3.27 萬 | 2026/3/26 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2026/3/2309:42 ET | Sabatini Brent高階主管 | 7,711 | $7.03 萬 | 2026/3/2310b5-1 | Fidelity Brokerage Services LLC | SEC |
| IOTSamsara Inc. | 2026/3/2016:40 ET | Adam Eltoukhy高階主管 | 1.64 萬 | $55.3 萬 | 2026/3/2010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| GWREGuidewire Software, Inc. | 2026/3/1719:26 ET | Jeffrey Elliott CooperChief Financial Officer | 1,935 | $31.7 萬 | 2026/3/17 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/3/1621:05 ET | Bobulsky Susan高階主管 | 4.13 萬 | $60.0 萬 | 2026/3/11 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/3/1621:00 ET | Benzeno Sharon高階主管 | 6.31 萬 | $91.6 萬 | 2026/3/11 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |